← Leaderboards
Barry E. Hurwitz
University Of Miami Coral Gables
$15,770,260
Attributed
$15,770,260
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–11$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$15,770,260 · 11
By mechanism
R01$12,029,648 · 4
P01$2,429,661 · 3
M01$1,260,843 · 3
U01$50,108 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Miami Coral Gables
Same institution · by research overlap
- Neil Schneiderman$30,680,907
- Shenghan Lai$32,566,126
- Jay S Skylar$445,946
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectHiv InfectionsAutonomic Nervous SystemHuman Therapy EvaluationEchocardiographyHeart FunctionMetabolic SyndromeCardiovascular DisorderOxidative StressReactive HyperemiaMethodologyCardiovascular SystemCardiacBlood VesselsResearch PersonnelLeft Ventricular MassStructureExercise Stress TestOverweightThickAdrenergic ReceptorInsulin Sensitivity /ResistanceDisease /Disorder Proneness /Risk
Grant awards (45)
Core--Cardiovascular Measures$196,501
P01 · FY2011 · HL · contact PI
Obesity, Metabolic Syndrome, Meal-Related Glycemia$783,675
R01 · FY2010 · HL · contact PI
Core--Cardiovascular Measures$196,501
P01 · FY2010 · HL · contact PI
Obesity, Metabolic Syndrome, Meal-Related Glycemia$730,118
R01 · FY2009 · HL · contact PI
Core--Cardiovascular Measures$196,502
P01 · FY2009 · HL · contact PI
Obesity, Metabolic Syndrome, Meal-Related Glycemia$40,328
R01 · FY2009 · HL · contact PI
Obesity, Metabolic Syndrome, Meal-Related Glycemia$731,552
R01 · FY2008 · HL · contact PI
Core--Cardiovascular Measures$192,571
P01 · FY2008 · HL · contact PI
Obesity, Metabolic Syndrome, Meal-Related Glycemia$749,306
R01 · FY2007 · HL · contact PI
Core--Cardiovascular Measures$196,501
P01 · FY2007 · HL · contact PI
HIV/HCV Co-infection: HAART and CVD Pathophysiology$611,050
R01 · FY2006 · HL · contact PI
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$70,230
R01 · FY2006 · DA · contact PI
HIV/HCV Co-infection: HAART and CVD Pathophysiology$609,848
R01 · FY2005 · HL
SELENIUM, HIV, AND CARDIOVASCULAR DISEASE RISK$337,385
M01 · FY2005 · RR
CORE C--CARDIOVASCULAR MEASUREMENT$182,973
P01 · FY2005 · HL
ANTI-HIV MEDICATIONS AND CARDIOVASCULAR DISEASE RISK$74,341
M01 · FY2005 · RR
RBC MASS/AUTONOMIC NERVOUS SYSTEM/INTEGRITY/SYNCOPE IN CHRONIC FATIGUE SYNDROME$28,827
M01 · FY2005 · RR
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$838,779
R01 · FY2004 · DA
Selenium, HIV, and Cardiovascular Disease Risk$750,785
M01 · FY2004 · RR
HIV/HCV Co-infection: HAART and CVD Pathophysiology$594,404
R01 · FY2004 · HL
CORE C--CARDIOVASCULAR MEASUREMENT$177,644
P01 · FY2004 · HL
RBC Mass/Autonomic Nervous System/Integrity/Syncope in Chronic Fatigue Syndrome$42,237
M01 · FY2004 · RR
ANTI-HIV MEDICATIONS AND CARDIOVASCULAR DISEASE RISK$27,268
M01 · FY2004 · RR
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$910,700
R01 · FY2003 · DA
HIV/HCV Co-infection: HAART and CVD Pathophysiology$579,031
R01 · FY2003 · HL
RBC MASS, ANS INTEGRITY &SYNCOPE SUSCEPTIBILITY IN CFS$475,828
R01 · FY2003 · HL
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$914,279
R01 · FY2002 · DA
HIV/HCV Co-infection: HAART and CVD Pathophysiology$581,055
R01 · FY2002 · HL
RBC MASS, ANS INTEGRITY &SYNCOPE SUSCEPTIBILITY IN CFS$462,188
R01 · FY2002 · HL
ACUTE STRESS RESPONSE IN HIV PRE AND POST CBSM$124,146
P01 · FY2002 · MH
ACUTE STRESS RESPONSE IN HIV PRE AND POST CBSM$124,146
P01 · FY2002 · MH
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$94,688
R01 · FY2002 · DA
CORE--CARDIOVASCULAR MEASUREMENT$0
P01 · FY2002 · HL
HEMODYNAMIC &AUTONOMIC MECHANISMS OF SYNCOPE SUSCEPTIBILITY IN CFS$0
U01 · FY2002 · AI
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$830,572
R01 · FY2001 · DA
RBC MASS, ANS INTEGRITY &SYNCOPE SUSCEPTIBILITY IN CFS$448,946
R01 · FY2001 · HL
ACUTE STRESS RESPONSE IN HIV PRE AND POST CBSM$124,146
P01 · FY2001 · MH
HEMODYNAMIC &AUTONOMIC MECHANISMS OF SYNCOPE SUSCEPTIBILITY IN CFS$0
U01 · FY2001 · AI
CORE--CARDIOVASCULAR MEASUREMENT$0
P01 · FY2001 · HL
DRUG ABUSE, HIV, SELENIUM SUPPLEMENTATION, AND CVD RISK$534,094
R01 · FY2000 · DA
RBC MASS, ANS INTEGRITY &SYNCOPE SUSCEPTIBILITY IN CFS$438,977
R01 · FY2000 · HL
ACUTE STRESS RESPONSE IN HIV PRE AND POST CBSM$272,084
P01 · FY2000 · MH
BEHAVIORAL REACTIVITY IN RELATION TO INDICES OF CHD RISK$222,973
P01 · FY2000 · HL
BEHAVIORAL REACTIVITY IN RELATION TO INDICES OF CHD RISK$222,973
P01 · FY2000 · HL
HEMODYNAMIC &AUTONOMIC MECHANISMS OF SYNCOPE SUSCEPTIBILITY IN CFS$50,108
U01 · FY2000 · AI